OSCR

Exploring the value of peritumoral brain zone for classification of two malignant brain tumors based on the MRI interpretable models.

Overview

Authors: Endong Zhao1, Yun-Feng Yang2,3, Hao Zhang1, Yuan-Yuan Yang2,3, Yutong Shi4, Beibei Li5, Xuelin Song1, Shiyun Lou5, Chao Yang1
  1. Department of Radiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000 China
  2. Laboratory for Medical Imaging Informatics, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai, 200083 China
  3. Laboratory for Medical Imaging Informatics, University of Chinese Academy of Sciences, Beijing, 100049 China
  4. Department of Neurology, Tianjin Medical University General Hospital, Tianjin, 300070 China
  5. Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000 China
Journal: BMC medical imaging, volume 26, issue 1, article 433
Dates: received 24 November 2024; accepted 11 May 2026; published online 26 May 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1186/s12880-026-02434-9 · PMID 42192376 · PMCID PMC13540937 · OpenAlex W7162413597
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: structural MRI / diffusion (modality), human (organism), other condition (population), clinical / translational (subfield)
Methods: Connectivity, Statistics, Machine learning, Preprocessing, fMRI & imaging
Keywords: Peritumoral brain zone, Radiomics, Interpretable model, Primary central nervous system lymphoma, Glioblastoma
MeSH: Brain Neoplasms*, Glioblastoma*, Image Interpretation, Computer-Assisted*, Lymphoma*, Magnetic Resonance Imaging*, Adult, Aged, Female, Humans, Male, Middle Aged, Radiomics, Retrospective Studies, ROC Curve, Sensitivity and Specificity (* major topic)
Topic: Brain Tumor Detection and Classification (Computer Vision and Pattern Recognition, Computer Science), according to OpenAlex
Funding: The Medical-Engineering Joint Fund between the First Affiliated Hospital of Dalian Medical University and Dalian Institute of Chemical Physics, Chinese Academy of Sciences. ((Grant No. DMU-1&DICP UN202403), (Grant No. DMU-1&DICP UN202403))
Citations: not cited yet (Europe PMC); 45 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

OnekeyAI-Platform

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: “Data availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it points to the authors' code: OnekeyAI-Platform
  • it says that the data are available on request

Read it in the paper: doi.org/10.1186/s12880-026-02434-9.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 5 keywords, 15 MeSH terms, 1 funder, 42 references.

Cite

This paper

Zhao, E., Yang, Y.-F., Zhang, H., Yang, Y.-Y., Shi, Y., Li, B., Song, X., Lou, S., & Yang, C. (2026). Exploring the value of peritumoral brain zone for classification of two malignant brain tumors based on the MRI interpretable models. BMC medical imaging, 26(1), 433. https://doi.org/10.1186/s12880-026-02434-9

BibTeX

@article{zhao2026exploring,
author = {Zhao, Endong and Yang, Yun-Feng and Zhang, Hao and Yang, Yuan-Yuan and Shi, Yutong and Li, Beibei and Song, Xuelin and Lou, Shiyun and Yang, Chao},
title = {{Exploring the value of peritumoral brain zone for classification of two malignant brain tumors based on the MRI interpretable models}},
journal = {BMC medical imaging},
year = {2026},
month = may,
volume = {26},
number = {1},
pages = {433},
publisher = {BMC},
issn = {1471-2342},
doi = {10.1186/s12880-026-02434-9},
url = {https://doi.org/10.1186/s12880-026-02434-9},
pmid = {42192376},
pmcid = {PMC13540937}
}

RIS

TY - JOUR
AU - Zhao, Endong
AU - Yang, Yun-Feng
AU - Zhang, Hao
AU - Yang, Yuan-Yuan
AU - Shi, Yutong
AU - Li, Beibei
AU - Song, Xuelin
AU - Lou, Shiyun
AU - Yang, Chao
TI - Exploring the value of peritumoral brain zone for classification of two malignant brain tumors based on the MRI interpretable models
T2 - BMC medical imaging
J2 - BMC Med Imaging
PY - 2026
DA - 2026/05/26
VL - 26
IS - 1
SP - 433
SN - 1471-2342
PB - BMC
DO - 10.1186/s12880-026-02434-9
UR - https://doi.org/10.1186/s12880-026-02434-9
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s12880-026-02434-9",
"type": "article-journal",
"title": "Exploring the value of peritumoral brain zone for classification of two malignant brain tumors based on the MRI interpretable models",
"container-title": "BMC medical imaging",
"author": [
{
"family": "Zhao",
"given": "Endong"
},
{
"family": "Yang",
"given": "Yun-Feng"
},
{
"family": "Zhang",
"given": "Hao"
},
{
"family": "Yang",
"given": "Yuan-Yuan"
},
{
"family": "Shi",
"given": "Yutong"
},
{
"family": "Li",
"given": "Beibei"
},
{
"family": "Song",
"given": "Xuelin"
},
{
"family": "Lou",
"given": "Shiyun"
},
{
"family": "Yang",
"given": "Chao"
}
],
"container-title-short": "BMC Med Imaging",
"volume": "26",
"issue": "1",
"page": "433",
"DOI": "10.1186/s12880-026-02434-9",
"PMID": "42192376",
"PMCID": "PMC13540937",
"ISSN": "1471-2342",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s12880-026-02434-9",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
26
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s40644-025-00967-w
Development and validation of a convolutional neural network for automatic differentiation of primary central nervous system lymphoma and glioblastoma.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
In common: structural MRI / diffusion, clinical / translational, other condition, 4 references
[2] doi:10.1158/2767-9764.crc-25-0710 [code]
MRI Deep Learning for Differentiating Glioblastoma, IDH Wild-type from Central Nervous System Diffuse Large B-cell Lymphoma.
Journal: Cancer research communications
In common: structural MRI / diffusion, clinical / translational, other condition, 4 references
[3] doi:10.1186/s40644-026-01052-6 [code]
Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
In common: structural MRI / diffusion, clinical / translational, other condition, 3 references
[4] doi:10.1016/j.isci.2024.109023 [code]
Deep learning aided preoperative diagnosis of primary central nervous system lymphoma.
Journal: iScience
In common: clinical / translational, other condition, 3 references
[5] doi:10.3389/fneur.2023.1107957 [code]
The value of convolutional neural networks-based deep learning model in differential diagnosis of space-occupying brain diseases.
Journal: Frontiers in neurology
In common: structural MRI / diffusion, clinical / translational, other condition, 2 references
[6] doi:10.3390/cancers15225460
Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.
Journal: Cancers
In common: other condition, 3 references
[7] doi:10.1038/s41597-022-01560-7 [code]
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics.
Journal: Scientific data
In common: structural MRI / diffusion, clinical / translational, other condition, 2 references
[8] doi:10.3389/fneur.2024.1474461 [code]
Utilizing machine-learning techniques on MRI radiomics to identify primary tumors in brain metastases.
Journal: Frontiers in neurology
In common: structural MRI / diffusion, clinical / translational, other condition, 2 references
[9] doi:10.1186/s13046-024-03157-x
SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4.
Journal: Journal of experimental & clinical cancer research : CR
In common: other condition, 3 references
[10] doi:10.1038/s41598-023-37723-8
Radiomics characterization of tissues in an animal brain tumor model imaged using dynamic contrast enhanced (DCE) MRI.
Journal: Scientific reports
In common: structural MRI / diffusion, other condition, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1186/s12880-026-02434-9.svg)](https://openscicode.org/badge/doi/10.1186/s12880-026-02434-9)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1186/s12880-026-02434-9.svg
   :target: https://openscicode.org/badge/doi/10.1186/s12880-026-02434-9
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1186/s12880-026-02434-9"><img src="https://openscicode.org/badge/doi/10.1186/s12880-026-02434-9.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.